Status:

COMPLETED

Red Cell Distribution With to Lymphocyte Ratio in Cardiac Surgery

Lead Sponsor:

Ankara City Hospital Bilkent

Conditions:

Cardiac Surgery

Eligibility:

All Genders

18+ years

Brief Summary

It is aimed to investigate whether red cell distribution with (RDW) to lymphocyte ratio (RLR) can predict early comorbidity among cardiac surgery patients.

Detailed Description

There are important developments in the field of cardiac surgery due to advances in medical treatments, surgical techniques, intraoperative anesthesia management, and postoperative intensive care. On ...

Eligibility Criteria

Inclusion

  • Adult patients undergoing open-heart surgery with cardiopulmonary bypass

Exclusion

  • Re-operations
  • Emergency operations
  • Patients with preoperative renal failure
  • Patients with preoperative hematological problems
  • Patients with preoperative infection
  • Patients with preoperative immunological disease
  • Patients using preoperative steroids

Key Trial Info

Start Date :

June 15 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2022

Estimated Enrollment :

700 Patients enrolled

Trial Details

Trial ID

NCT05341037

Start Date

June 15 2022

End Date

August 1 2022

Last Update

August 8 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ankara City Hospital

Ankara, Turkey (Türkiye)

Red Cell Distribution With to Lymphocyte Ratio in Cardiac Surgery | DecenTrialz